151 related articles for article (PubMed ID: 36473359)
1. Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress.
Blach S; Brown KA; Brown RS; Gholam PM; Terrault NA; Estes C; Razavi HA
J Infect Public Health; 2023 Jan; 16(1):64-70. PubMed ID: 36473359
[TBL] [Abstract][Full Text] [Related]
2. Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study.
Barocas JA; Savinkina A; Lodi S; Epstein RL; Bouton TC; Sperring H; Hsu HE; Jacobson KR; Schechter-Perkins EM; Linas BP; White LF
Clin Infect Dis; 2022 Aug; 75(1):e1112-e1119. PubMed ID: 34499124
[TBL] [Abstract][Full Text] [Related]
3. Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany.
Tergast TL; Blach S; Tacke F; Berg T; Cornberg M; Kautz A; Manns M; Razavi H; Sarrazin C; Serfert Y; van Thiel I; Zeuzem S; Wedemeyer H
J Viral Hepat; 2022 Jul; 29(7):536-542. PubMed ID: 35357770
[TBL] [Abstract][Full Text] [Related]
4. Estimating the Year Each State in the United States Will Achieve the World Health Organization's Elimination Targets for Hepatitis C.
Sulkowski M; Cheng WH; Marx S; Sanchez Gonzalez Y; Strezewski J; Reau N
Adv Ther; 2021 Jan; 38(1):423-440. PubMed ID: 33145648
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID-19.
Blach S; Blomé M; Duberg AS; Jerkeman A; Kåberg M; Klasa PE; Lagging M; Razavi-Shearer D; Razavi H; Aleman S
Liver Int; 2021 Sep; 41(9):2024-2031. PubMed ID: 34051065
[TBL] [Abstract][Full Text] [Related]
6. Securing wider EU commitment to the elimination of hepatitis C virus.
Wedemeyer H; Tergast TL; Lazarus JV; Razavi H; Bakoyannis K; Baptista-Leite R; Bartoli M; Bruggmann P; Buşoi CS; Buti M; Carballo M; Castera L; Colombo M; Coutinho RS; Dadon Y; Esmat G; Esteban R; Farran JC; Gillyon-Powell M; Goldberg D; Hutchinson S; Janssen HLA; Kalamitsis G; Kondili LA; Lambert JS; Marinho RT; Maticic M; Patricello A; Peck-Radosavljevic M; Pol S; Poljak M; Pop C; Sokol T; Sypsa V; Tözün N; Younossi Z; Aghemo A; Papatheodoridis GV; Hatzakis A
Liver Int; 2023 Feb; 43(2):276-291. PubMed ID: 36196744
[TBL] [Abstract][Full Text] [Related]
7. Progress on global hepatitis elimination targets.
Waheed Y
World J Gastroenterol; 2021 Dec; 27(47):8199-8200. PubMed ID: 35068864
[TBL] [Abstract][Full Text] [Related]
8. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
[TBL] [Abstract][Full Text] [Related]
9. Modelling the microelimination of chronic hepatitis C in the canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy goals despite the impact of the COVID 19 pandemic.
Schorr O; Blach S; Thurnheer C; Ruis C; Dufour JF
PLoS One; 2022; 17(8):e0272518. PubMed ID: 35960770
[TBL] [Abstract][Full Text] [Related]
10. Forecasting the long-term impact of COVID-19 on hepatitis C elimination plans in Italy: A mathematical modelling approach.
Kondili LA; Andreoni M; Aghemo A; Mastroianni CM; Merolla R; Gallinaro V; D'Offizi G; Craxì A
Liver Int; 2023 Dec; 43(12):2615-2624. PubMed ID: 37735959
[TBL] [Abstract][Full Text] [Related]
11. A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea.
Won YK; Kang KS; Gonzalez YS; Razavi H; Dugan E; Han KH; Ahn SH; Jeon MY; Kim DY
PLoS One; 2020; 15(4):e0232186. PubMed ID: 32343727
[TBL] [Abstract][Full Text] [Related]
12. Impact of Coronavirus Disease 2019 Pandemic on Viral Hepatitis Elimination: What Is the Price?
Sowah L; Chiou C
AIDS Res Hum Retroviruses; 2021 Aug; 37(8):585-588. PubMed ID: 33913731
[TBL] [Abstract][Full Text] [Related]
13. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.
Polaris Observatory HCV Collaborators
Lancet Gastroenterol Hepatol; 2022 May; 7(5):396-415. PubMed ID: 35180382
[TBL] [Abstract][Full Text] [Related]
14. Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic.
Tai CM; Huang CK; Changchien TC; Lin PC; Wang DW; Chang TT; Chan HW; Chen TH; Tseng CH; Chen CC; Tsai CT; Sie YT; Yen YC; Yu ML
Viruses; 2022 Jul; 14(8):. PubMed ID: 35893702
[TBL] [Abstract][Full Text] [Related]
15. Viral hepatitis C pandemic: Challenges and threats to its elimination.
Krekulova L; Honzák R; Riley LW
J Viral Hepat; 2021 May; 28(5):694-698. PubMed ID: 33550694
[TBL] [Abstract][Full Text] [Related]
16. HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemic.
Hartl L; Jachs M; Bauer D; Simbrunner B; Chromy D; Binter T; Steininger L; Schwarz C; Schwarz M; Burghart L; Strassl R; Trauner M; Gschwantler M; Mandorfer M; Reiberger T
J Viral Hepat; 2022 Dec; 29(12):1062-1072. PubMed ID: 36062398
[TBL] [Abstract][Full Text] [Related]
17. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
[TBL] [Abstract][Full Text] [Related]
18. Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021.
Meyer ED; Dudareva S; Kollan C; Mauss S; Wedemeyer H; Schmidt D; Zimmermann R
Front Public Health; 2023; 11():1149694. PubMed ID: 37325322
[TBL] [Abstract][Full Text] [Related]
19. Global timing of hepatitis C virus elimination in high-income countries.
Razavi H; Sanchez Gonzalez Y; Yuen C; Cornberg M
Liver Int; 2020 Mar; 40(3):522-529. PubMed ID: 31815353
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C elimination among people who inject drugs in Mexico during the COVID-19 pandemic.
Márquez LK; Borquez A; Fleiz C; Magis-Rodríguez C; Rangel G; Strathdee SA; Martin NK
Gac Med Mex; 2022; 158(2):110-113. PubMed ID: 35763823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
